Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly Active Hydrogen Evolution Achieved by Microwave-Assisted Rapid Anchoring of Single Platinum Atom on S-Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub>.

ChemSusChem·2026
Same author

Rheology of MXene-reinforced dual-network hydrogels in swollen and unswollen states.

Soft matter·2026
Same author

CT-Based Assessment of Brain Edema May Predict Which Patients with Traumatic Brain Injury May Benefit from Tranexamic Acid.

AJNR. American journal of neuroradiology·2026
Same author

Impact of Imaging Acquisition and Protocol Variability on Artificial Intelligence Model Performance: A Secondary Analysis of the ASFNR Artificial Intelligence Competition.

AJNR. American journal of neuroradiology·2026
Same author

MRI Findings of Intracranial Hemorrhages in ARCADIA-MRI: An Ancillary Study to the ARCADIA Trial.

AJNR. American journal of neuroradiology·2025
Same author

The Latest Advances in Mechanically Robust Self-Healing Polyurea Based on Dynamic Chemistry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Related Experiment Video

Updated: Jul 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K

Targeting CD24 as a novel immunotherapy for solid cancers.

Yan Yang1, Guangming Zhu2, Li Yang3

  • 1Xinxiang Engineering Technology Research Center of Tumor-Targeted Drug Development, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453000, Henan, China.

Cell Communication and Signaling : CCS
|November 3, 2023
PubMed
Summary

Cluster of differentiation 24 (CD24) is a key cancer stem cell marker and immune checkpoint in solid tumors. Targeting CD24 offers a promising therapeutic strategy for cancer treatment.

Keywords:
CD24Cancer Stem CellsCell signalingImmune checkpoint inhibitorsImmunotherapySolid cancer

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

554

Related Experiment Videos

Last Updated: Jul 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

554

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cluster of differentiation 24 (CD24) is a highly glycosylated molecule implicated in cancer stem cell properties.
  • CD24 functions by interacting with ligands or through signal transduction pathways, influencing neoplasm initiation and progression.

Discussion:

  • CD24 has emerged as a critical innate immune checkpoint in various solid cancers.
  • Its role extends beyond cancer stemness to modulating the tumor immune microenvironment.

Key Insights:

  • CD24's molecular mechanisms in tumorigenesis and cancer progression are increasingly understood.
  • It represents a significant and promising therapeutic target for solid tumors.

Outlook:

  • Review of current therapeutic agents and strategies targeting CD24 in solid cancers.
  • Future research directions for CD24-based cancer therapies.